{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 459536761
| IUPAC_name = 1-benzoyl-5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione
| image = Benzobarbital.png
| width = 200
| image2 = Benzobarbital ball-and-stick.png
<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 744-80-9
| ATC_prefix = none
| ATC_suffix = 
| PubChem = 12938
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1338506
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =    
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = YNJ78BD0AH
| synonyms = Benzonal
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 12402


<!--Chemical data-->
| C=19 | H=16 | N=2 | O=4 
| molecular_weight = 336.341 g/mol
| smiles = CCC1(C(=O)NC(=O)N(C1=O)C(=O)C2=CC=CC=C2)C3=CC=CC=C3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H16N2O4/c1-2-19(14-11-7-4-8-12-14)16(23)20-18(25)21(17(19)24)15(22)13-9-5-3-6-10-13/h3-12H,2H2,1H3,(H,20,23,25)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = QMOWPJIFTHVQMB-UHFFFAOYSA-N
}}

'''Benzobarbital''' (Benzonal) is a [[barbiturate]] derivative. It has [[anticonvulsant]] effects and has been used for the treatment of [[epilepsy]].
<ref>{{Cite journal 
| last1 = Okudzhava    | first1 = V. M. 
| last2 = Chankvetadze | first2 = B. G. 
| title = Pharmacological characteristics of an anti-convulsive drug Benzonal and the evaluation of its therapeutic effectiveness (literature review) 
| journal  = Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova
| language = russian
| location = Moscow
| volume   = 89 
| issue    = 11 
| pages    = 136–145 
| year     = 1989 
| pmid     = 2696306
| issn     =  0044-4588 
}}</ref>

It has similar liver enzyme inducing effects to the closely related drug [[phenobarbital]], which may be exploited in some clinical applications.
<ref>{{Cite journal 
| last1 = Nadzhimutdinov | first1 = K. N. 
| last2 = Khakimov       | first2 = Z. Z. 
| last3 = Kabulov        | first3 = Sh. M.
| title = The advantages of benzonal as an inducer of the liver mono-oxygenase enzyme system compared to phenobarbital 
| language = russian
| journal  = Eksperimental'naia i klinicheskaia farmakologiia 
| location = Moscow
| issn     = 0869-2092
| volume   = 55 
| issue    = 1 
| pages    = 68–71 
| year    = 1992 
| pmid    = 1305441
}}</ref>
<ref>{{Cite journal 
| last1 = Novozheeva   | first1 = T. P. 
| last2 = Saratikov    | first2 = A. S. 
| last3 = Grishanova   | first3 = A. U. 
| last4 = Gutkina      | first4 = N. I. 
| last5 = Akhmedzhanov | first5 = R. R. 
| last6 = Khatsenko    | first6 = O. G. 
| last7 = Kozlovskaia  | first7 = N. E. 
| title = Benzonal--a phenobarbital-type of inducer of the mono-oxygenase system 
| language = russian
| journal = Biulleten' eksperimental'noi biologii i meditsiny 
| issn   = 0365-9615
| oclc   = 613807502
| location = Moscow
| volume = 111 
| issue  = 2 
| pages  = 163–165 
| year   = 1991 
| pmid   = 1854958
}}</ref>

== References ==
{{reflist}}


{{Hypnotics and sedatives}}
{{GABAAR PAMs}}

[[Category:Barbiturates]]
[[Category:GABAA receptor positive allosteric modulators]]


{{sedative-stub}}